Seeing Is Believing
Currently out of the existing stock ratings of Gena Wang, 209 are a BUY (66.99%), 72 are a HOLD (23.08%), 31 are a SELL (9.94%).
Analyst Gena Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 62.94% that have a potential upside of 23.86% achieved within 178 days.
Gena Wang’s has documented 612 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Energy, Technology sectors.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 30-Jul-2025.
Analyst best performing recommendations are on SMCI (SUPER MICRO COMPUTER).
The best stock recommendation documented was for SMCI (SUPER MICRO COMPUTER) at 2/13/2024. The price target of $961 was fulfilled within 2 days with a profit of $169.51 (21.42%) receiving and performance score of 107.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$478
$85.76 (21.86%)
$377
6 days ago
(31-Jul-2025)
21/22 (95.45%)
$85.76 (21.86%)
192
Buy
$370
$-22.24 (-5.67%)
$298
7 days ago
(30-Jul-2025)
10/10 (100%)
$30.2 (8.89%)
89
Buy
$348
$-44.24 (-11.28%)
$338
21 days ago
(16-Jul-2025)
7/7 (100%)
$25.19 (7.80%)
28
Buy
$359
$-33.24 (-8.47%)
$325
26 days ago
(11-Jul-2025)
9/9 (100%)
$44.06 (13.99%)
146
Buy
$384
$-8.24 (-2.10%)
$238
30 days ago
(07-Jul-2025)
8/8 (100%)
$59.87 (18.47%)
108
Which stock is Gena Wang is most bullish on?
Which stock is Gena Wang is most reserved on?
What Year was the first public recommendation made by Gena Wang?